Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com
Clinical Trial ID: NCT04014205
A Phase I/II Multicenter, Open-Label, Study of a Novel Bruton s Tyrosine Kinase Inhibitor, Orelabrutinib, in Patients with B-Cell Malignancies
Status
Open
Conditions
Other
Phases
II
Age Group
Adult
Main Investiagtor
Norkin, Maxim
Practice
Lymphoma
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT04014205
Secondary Trial ID Number
ICP-CL-00107
Keywords
Treatment